Atorvastatin lowers (68)Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes

AIMS/HYPOTHESIS: Inflammation is a core component of residual cardiovascular risk in type 2 diabetes. With new anti-inflammatory therapeutics entering the field, accurate markers to evaluate their effectiveness in reducing cardiovascular disease are paramount. Gallium-68-labelled DOTATATE ((68)Ga-DO...

Descripción completa

Detalles Bibliográficos
Autores principales: Oostveen, Reindert F., Kaiser, Yannick, Ståhle, Mia R., Nurmohamed, Nick S., Tzolos, Evangelos, Dweck, Marc R., Kroon, Jeffrey, Murphy, Andrew J., Dey, Damini, Slomka, Piotr J., Verberne, Hein J., Stroes, Erik S. G., Hanssen, Nordin M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542709/
https://www.ncbi.nlm.nih.gov/pubmed/37581619
http://dx.doi.org/10.1007/s00125-023-05990-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542709/
https://www.ncbi.nlm.nih.gov/pubmed/37581619
http://dx.doi.org/10.1007/s00125-023-05990-9

Ejemplares similares